Year | ≤ '19 | '20 | '21 | '22 | '23 | '24 | T |
---|---|---|---|---|---|---|---|
Buyside (0.4/yr) | - | - | - | 1 | 1 | - | 2 |
Sellside (0.2/yr) | - | - | 1 | - | - | - | 1 |
3 |
Target Company | Date | Value | Type |
---|---|---|---|
Sign-up to View | 2023-12-22 | 14.0B USD | Life Science |
Sign-up to View | 2022-06-03 | 4.1B USD | Life Science |
Sign-up to View | 2021-07-26 | 520M USD | Metals/Mining |
View All >> |
Sector | # | Value | |
---|---|---|---|
Life Science | Sign-up to View | ||
Metals/Mining | Sign-up to View | ||
Total | Sign-up to View |
State/Country | # | Value | |
---|---|---|---|
United States | Sign-up to View | ||
Massachusetts | Sign-up to View | ||
California | Sign-up to View | ||
Delaware | Sign-up to View | ||
Total | Sign-up to View |
Type | # | Value | |
---|---|---|---|
Add-on Acquisition | Sign-up to View | ||
Divestiture | Sign-up to View | ||
Total | Sign-up to View |
Corporate (2) | Deals |
---|---|
Sign-up to View |
2 |
Sign-up to View |
1 |
Value | # | TOTAL |
---|---|---|
> $1B | Sign-up to View | |
$100M to $1B | Sign-up to View | |
< $100M | Sign-up to View | |
TOTAL | Sign-up to View | |
Largest |
Karuna Therapeutics, Inc. $14.0B (2023-12-22) |